Mankind Pharma vs JB Chemicals and Pharmaceuticals: Share Price, Comparison and Key Differences

Mankind Pharma MCap Rs 1,00,395 Cr, PE 48.56x, ROE 11.74%, D/E 0.39. JB Chemicals MCap Rs 38,731 Cr, PE 54.59x, ROE 17.06%, zero debt, Div 0.91%.

Updated: 10 Aug 2026 • 1:53 pm

Posted by:

Mankind Pharma vs JB Chemicals and Pharmaceuticals: Share Price, Comparison and Key Differences

Mankind Pharma vs JB Chemicals and Pharmaceuticals is a comparison branded generics investors look up when evaluating two of India's most recognised listed pharmaceutical companies. Mankind Pharma is India's fourth largest pharma company by domestic sales, known for its mass-market branded generics at affordable prices – including Manforce, Gas-O-Fast and Moxikind-CV. JB Chemicals, backed by KKR since 2020, is known for its high-margin cardiac, cardiology and gastrointestinal brands – including Metrogyl, Rantac and Cilacar.

This Mankind Pharma vs JB Chemicals and Pharmaceuticals article covers reach and market position, key products, latest declared results and stock valuation. The Mankind Pharma vs JB Chemicals and Pharmaceuticals data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.

Table of Contents

Mankind Pharma vs JB Chemicals and Pharmaceuticals: Reach and Market Position

On the Mankind Pharma side of the Mankind Pharma vs JB Chemicals and Pharmaceuticals comparison, Mankind Pharma distributes across every tier of India's prescribing network with a field force of 12,000+ covering urban, semi-urban and rural markets. Market capitalisation is Rs 1,00,395 Cr.

Click Here – Get Free Investment Predictions

On the JB Chemicals and Pharmaceuticals side of the Mankind Pharma vs JB Chemicals and Pharmaceuticals comparison, JB Chemicals has a lean but highly productive field force focused on cardiology, gastroenterology and cough-cold segments, selling high-brand-recall products to specialists. Market capitalisation is Rs 38,731 Cr.

Mankind Pharma vs JB Chemicals and Pharmaceuticals: Key Products and Business Mix

In the Mankind Pharma vs JB Chemicals and Pharmaceuticals product comparison, Mankind Pharma offers: Mankind Pharma earns from branded generics in cardiac, anti-infective, gynaecology, OTC (Gas-O-Fast, Combiflam-like) and consumer health (Manforce condoms). EPS is Rs 50.06. PE is 48.56x, ROE 11.74 percent, D/E 0.39.

For JB Chemicals and Pharmaceuticals in this Mankind Pharma vs JB Chemicals and Pharmaceuticals breakdown: JB Chemicals earns from cardiology (Cilacar, Nicardia), GI (Metrogyl, Rantac), cough-cold and international exports. EPS is Rs 44.19. PE is 54.59x, ROE 17.06 percent, zero debt, Div 0.91 percent.

Mankind Pharma vs JB Chemicals and Pharmaceuticals: Latest Results

The Mankind Pharma vs JB Chemicals and Pharmaceuticals results for Mankind Pharma: Mankind Pharma has a market cap of Rs 1,00,395 Cr and PE of 48.56x. ROE is 11.74 percent. Mankind is 2.6 times larger than JB Chemicals by market cap.

The Mankind Pharma vs JB Chemicals and Pharmaceuticals results for JB Chemicals and Pharmaceuticals: JB Chemicals has a market cap of Rs 38,731 Cr and PE of 54.59x. ROE is 17.06 percent – significantly above Mankind. JB Chemicals has zero debt and pays a dividend of 0.91 percent yield.

Compare Mankind Pharma and JB Chemicals and Pharmaceuticals Fundamentals on the Univest Screener

Mankind Pharma vs JB Chemicals and Pharmaceuticals: Stock and Valuation

The Mankind Pharma vs JB Chemicals and Pharmaceuticals stock comparison uses the latest available market data from Groww. Investors tracking Mankind Pharma vs JB Chemicals and Pharmaceuticals should verify current prices on NSE or BSE before trading.

Mankind Pharma vs JB Chemicals at current valuations: Mankind trades at Rs 1,00,395 Cr market cap, PE 48.56x, ROE 11.74 percent. JB Chemicals trades at Rs 38,731 Cr market cap, PE 54.59x, ROE 17.06 percent, zero debt. JB Chemicals has a higher ROE and zero debt but is more expensive on PE.

Mankind Pharma vs JB Chemicals and Pharmaceuticals: Quick Comparison Table

The Mankind Pharma vs JB Chemicals and Pharmaceuticals comparison table below summarises the key metrics covered in this article side by side.

Parameter	Mankind Pharma	JB Chemicals and Pharmaceuticals
Sector	Mass market branded generics + OTC (pan-India)	Cardiac, GI, cough branded generics (high-ROE model)
Market Cap	Rs 1,00,395 Cr	Rs 38,731 Cr
P/E Ratio	48.56x	54.59x
ROE	11.74%	17.06%
Debt to Equity	0.39	Zero
Dividend	0.04% yield	0.91% yield
Ownership	Juneja family (promoter)	KKR (PE-backed, majority stake)

Conclusion

The Mankind Pharma vs JB Chemicals and Pharmaceuticals comparison above covers the key data points on reach, products, results and valuation. Mankind Pharma vs JB Chemicals covers two Indian branded generic companies with strong domestic prescription franchises. Mankind is the volume leader in affordable branded generics across mass therapy areas. JB Chemicals has a high-ROE model built on cardiac and GI brand leadership. Mankind Pharma vs JB Chemicals investors should review India prescription growth by therapy, brand market share, field force productivity and KKR's strategic direction for JB Chemicals. Mankind Pharma vs JB Chemicals both represent quality India branded pharma – consult a SEBI-registered advisor for personalised guidance.

Download the Univest iOS App or Univest Android App to track Mankind Pharma and JB Chemicals and Pharmaceuticals live price and get daily stock recommendations.

Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What drugs does Mankind Pharma sell?

Ans. Mankind Pharma sells a wide range of branded generics including cardiac drugs, anti-infectives, fertility drugs and popular OTC products like Gas-O-Fast (antacid), and runs the condom brand Manforce.

What is JB Chemicals known for?

Ans. JB Chemicals is known for Metrogyl (metronidazole antibiotic), Rantac (ranitidine antacid), Cilacar (cilnidipine cardiac) and Nicardia (nifedipine cardiac). KKR acquired a majority stake in 2020.

Does JB Chemicals have debt?

Ans. JB Chemicals is a zero-debt company. This is unusual for a mid-size pharma company that has also been growing through acquisitions.

Does Mankind Pharma have OTC brands?

Ans. Yes. Mankind has OTC consumer health brands including Manforce condoms, Gas-O-Fast antacid tablets, Unwanted Kit (emergency contraceptive) and Prega News (home pregnancy test).

Is Mankind Pharma in Nifty 50?

Ans. Mankind Pharma completed its IPO in 2023 and is tracked in Nifty 500. It is not in Nifty 50 currently.

What is the KKR connection to JB Chemicals?

Ans. KKR (Kohlberg Kravis Roberts), the US private equity firm, acquired a majority stake in JB Chemicals in 2020. Under KKR, JB Chemicals has focused on premium brands and international growth.